Winlevi Attracts Interest From Multiple Industry Players
Canadian Launch From Sun Accompanied By Fresh Deals With Glenmark And Hikma
As Sun Pharma announces a Canadian launch for its licensed Winlevi clascoterone cream dermatology asset, the firm’s originating partner Cassiopea has struck further deals with Hikma and Glenmark for the acne treatment to be sold in Europe, the MENA region and South Africa.
